United States · FDA National Drug Code directory

Hydromorphone Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63629-4284_f895b5fa-f576-4ee7-9747-ada5688ca1ab
Product NDC
63629-4284
Form
TABLET
Composition / generic term
Hydromorphone Hydrochloride
Labeler
Bryant Ranch Prepack
Marketing category
NDA AUTHORIZED GENERIC
Marketing start / end (source format)
20091123
Source listing expiry
20271231

Source-listed ingredients

  • HYDROMORPHONE HYDROCHLORIDE — 2 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 25 TABLET in 1 BOTTLE (63629-4284-1) · 63629-4284-1
  • 60 TABLET in 1 BOTTLE (63629-4284-2) · 63629-4284-2
  • 30 TABLET in 1 BOTTLE (63629-4284-3) · 63629-4284-3
  • 28 TABLET in 1 BOTTLE (63629-4284-4) · 63629-4284-4
  • 90 TABLET in 1 BOTTLE (63629-4284-5) · 63629-4284-5
  • 120 TABLET in 1 BOTTLE (63629-4284-6) · 63629-4284-6
  • 40 TABLET in 1 BOTTLE (63629-4284-7) · 63629-4284-7
  • 20 TABLET in 1 BOTTLE (63629-4284-8) · 63629-4284-8
  • 10 TABLET in 1 BOTTLE (63629-4284-9) · 63629-4284-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →